TIENGO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.677
AS - Asia 5.272
EU - Europa 2.295
AF - Africa 890
SA - Sud America 789
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 60
Totale 21.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.100
SG - Singapore 1.663
CN - Cina 1.003
VN - Vietnam 709
HK - Hong Kong 503
BR - Brasile 430
FI - Finlandia 286
IT - Italia 254
FR - Francia 252
BD - Bangladesh 207
SE - Svezia 206
DE - Germania 198
IN - India 155
GB - Regno Unito 129
UA - Ucraina 126
RU - Federazione Russa 87
IQ - Iraq 80
PL - Polonia 74
AR - Argentina 73
CA - Canada 72
TR - Turchia 71
PH - Filippine 54
PK - Pakistan 54
ID - Indonesia 51
JP - Giappone 49
ZA - Sudafrica 47
GT - Guatemala 44
SA - Arabia Saudita 44
MX - Messico 43
MY - Malesia 43
CO - Colombia 41
TT - Trinidad e Tobago 40
UZ - Uzbekistan 39
EC - Ecuador 38
MA - Marocco 38
NL - Olanda 38
ES - Italia 37
TH - Thailandia 37
IE - Irlanda 36
IL - Israele 36
VE - Venezuela 36
KE - Kenya 35
PY - Paraguay 34
CL - Cile 32
MN - Mongolia 32
PE - Perù 32
GH - Ghana 31
IS - Islanda 31
TN - Tunisia 31
BB - Barbados 30
DZ - Algeria 30
MD - Moldavia 30
CV - Capo Verde 29
CW - ???statistics.table.value.countryCode.CW??? 29
AE - Emirati Arabi Uniti 28
CR - Costa Rica 28
HN - Honduras 28
JM - Giamaica 28
JO - Giordania 28
PR - Porto Rico 28
DJ - Gibuti 27
RS - Serbia 27
TZ - Tanzania 27
RO - Romania 26
SK - Slovacchia (Repubblica Slovacca) 26
UY - Uruguay 26
BO - Bolivia 25
CZ - Repubblica Ceca 25
EG - Egitto 25
KZ - Kazakistan 25
PS - Palestinian Territory 25
SN - Senegal 25
BE - Belgio 24
HR - Croazia 24
HT - Haiti 24
MR - Mauritania 24
PA - Panama 24
UG - Uganda 24
AL - Albania 23
AT - Austria 23
BG - Bulgaria 23
BS - Bahamas 23
BY - Bielorussia 23
DO - Repubblica Dominicana 23
EE - Estonia 23
LY - Libia 23
NE - Niger 23
NP - Nepal 23
XK - ???statistics.table.value.countryCode.XK??? 23
CY - Cipro 22
ME - Montenegro 22
MG - Madagascar 22
NO - Norvegia 22
PT - Portogallo 22
ZM - Zambia 22
AM - Armenia 21
AU - Australia 21
DK - Danimarca 21
GF - Guiana Francese 21
NC - Nuova Caledonia 21
Totale 20.040
Salva come PNG Salva come JPEG
Città #
Fairfield 1.323
San Jose 1.027
Singapore 1.015
Ashburn 955
Woodbridge 783
Chandler 670
Houston 646
Jacksonville 587
Wilmington 485
Ann Arbor 483
Seattle 480
Hong Kong 465
Cambridge 462
Council Bluffs 214
Beijing 204
Princeton 201
Boardman 181
Ho Chi Minh City 160
Dong Ket 155
Santa Clara 152
Helsinki 136
Los Angeles 136
Hanoi 128
San Diego 126
Roxbury 123
Lauterbourg 113
Nanjing 94
Guangzhou 83
Des Moines 66
Medford 62
Bytom 53
New York 53
Chicago 41
Shanghai 37
São Paulo 37
Tashkent 37
Shenyang 34
Hebei 30
Milan 30
Nairobi 30
Dublin 29
Ulan Bator 29
Accra 28
Dallas 28
Rome 28
Amman 27
Guatemala City 27
Haiphong 27
Nanchang 27
Norwalk 26
Praia 26
Bridgetown 25
Buffalo 25
Dakar 25
Reykjavik 25
Da Nang 24
Jeddah 24
Kuala Lumpur 24
Montevideo 24
Tokyo 24
Baghdad 23
Munich 23
Panama City 23
Kampala 22
Nassau 22
Dar es Salaam 21
Managua 21
Nouakchott 21
Noumea 21
Orem 21
San José 21
Willemstad 21
Dushanbe 20
Jiaxing 20
Lusaka 20
Bishkek 19
Changsha 19
Djibouti 19
Frankfurt am Main 19
London 19
Podgorica 19
Antananarivo 18
Baku 18
Harare 18
Johannesburg 18
Turku 18
Yerevan 18
Andorra la Vella 17
Chisinau 17
Kingston 17
Libreville 17
Lima 17
Ljubljana 17
Minsk 17
Niamey 17
Tianjin 17
Vienna 17
Abidjan 16
Atlanta 16
Brooklyn 16
Totale 13.379
Salva come PNG Salva come JPEG
Nome #
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 329
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 316
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 304
Pravastatin inhibits insulin-mediated production of reactive oxygen species by a protein kinase C-dependent mechanism in human skin fibroblasts ex vivo. Effects on insulin signaling 282
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 270
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 267
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 262
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 247
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 244
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 236
Mechanisms of acute and chronic hypoglycemic action of gliclazide 233
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 232
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 232
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 228
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 227
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 226
Dose-response curves of effects of insulin on leucine kinetics in humans. 226
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 223
Endothelial progenitor cells and the diabetic paradox. 221
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 220
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 219
Role of anti-granulocyte Fab ' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results 219
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 219
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 216
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 214
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 214
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 213
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 210
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. 204
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 203
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 202
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 201
The metabolic syndrome, diabetes and lung dysfunction. 199
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia 191
Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. 190
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 190
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. 187
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 185
Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: A low molecular weight factor possibly involved 184
Characteristics and mortality oftype 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia. 181
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 181
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 181
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. 180
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 179
Circulating progenitor cells in the natural history of type 2 diabetes mellitus 175
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 171
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients 169
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus 168
The metabolic syndrome, diabetes and lungdysfunction. 167
Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. 166
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 166
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. 165
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 164
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 163
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 163
Continuous subcutaneous glucose monitoring in diabetic patients - A multicenter analysis 162
Glucose tolerance is negatively associated with circulating progenitor cell levels. 161
Sequelae of acute hypoglycaemia on 24 hour blood pressure and metabolic parameters in normal and type 1 (insulin-dependent) diabetic individuals. 159
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 159
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 158
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 158
First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen. 157
Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. 156
Early myocardial dysfunction in the diabetic heart: Current research and clinical applications 154
The effect of continuous subcutaneous insulin infusion treatment on proliferative diabetic retinopathy. 154
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 154
The use of degrees of certainty to evaluate knowledge 153
Alcohol impairs insulin sensitivity in normal subjects. 153
Glucose tolerance during moderate alcohol intake: Insights on insulin action from glucose/lactate dynamics 153
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 152
Non esterified fatty acids and endothelial dysfunction 151
Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus 149
The effects of oral amino acid intake on ambulatory capacity in elderly subjects 147
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes 146
Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition 145
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients 143
INTRA-ARTERIAL CALCIUM INJECTION TEST AS LOCALIZING PROCEDURE IN INSULINOMAS. 143
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 141
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 140
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 140
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 138
Relationship between plasma leucine concentration and clearance in normal and type 1 diabetic subjects. 137
Model of the kinetics of ketone bodies in humans. 137
Continuous glucose monitoring in conditions other than diabetes 137
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. 136
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. 136
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. 136
Continuous subcutaneous insulin infusion (CSII) in Italy 134
Effect of different times of administration of a single ethanol dose on insulin action, insulin secretion and redox state. 132
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 131
Role of intra-arterial calcium injection test and venous sampling (IACI) as localizing procedure in insulinomas. 129
Extreme but asymptomatic hypergastrinemia with gastroparesis in a young woman with insulin dependent diabetes mellitus. 129
Ketone body metabolism in normal and diabetic human skeletal muscle. 128
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria 127
Protein metabolism in Type 1 and Type 2 diabetes mellitus in the fasted and fed states. 126
PROTEIN METABOLISM IN GLUCAGONOMA. 126
A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII 126
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations 126
Accuracy of continuous subcutaneous glucose monitoring in detecting hypoglycemia in diabetic patients 126
A post-hypoglycaemic increase of lactate can rescue cognitive function and counterregulatory responses to hypoglycaemia 126
Totale 18.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.224
article - articoli 53.906
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.219
Totale 116.349
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.419 0 0 219 109 64 120 74 162 98 25 200 348
2022/20231.319 248 142 9 179 206 174 1 110 171 7 57 15
2023/2024503 18 87 56 38 30 32 16 9 16 80 52 69
2024/20252.183 6 182 136 84 297 37 85 144 195 74 409 534
2025/20268.473 236 822 1.210 1.363 706 355 1.042 829 928 486 313 183
2026/20271.210 275 518 417 0 0 0 0 0 0 0 0 0
Totale 21.070